Product Information

LAMICTAL XR 250 MG TABLET is a brand product labeled by GlaxoSmithKline LLC, priced at $44.3107 per EA under NDC 00173078100. Its NADAC has been published 171 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the lamotrigine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LAMICTAL XR 250 MG TABLET

lamotrigine

$44.3107per EA

High Outlier

Strength

250 mg/1

Manufacturer

GlaxoSmithKline LLC

NDC

00173078100

Classification

Brand

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

LAMOTRIGINE

Approval Type

New Drug (NDA)

FDA Application

NDA022115

On Market Since

8/15/2011

Pharmacological Classes

Anti-epileptic Agent

Decreased Central Nervous System Disorganized Electrical Activity

Dihydrofolate Reductase Inhibitors

Mood Stabilizer

Organic Cation Transporter 2 Inhibitors

Price Statistics

The NADAC for LAMICTAL XR 250 MG TABLET has been published 171 times since Nov 28, 2013, and over the history we have for it it has risen 142.3%. The table below summarizes its recorded NADAC range and movement.

Current price	$44.3107 per EA
All-time high	$44.3107 (Jun 24, 2026)
All-time low	$18.2864 (Nov 28, 2013)
52-week high	$44.3107
52-week low	$42.8774
Median price	$41.8617
Average price	$38.0279
Largest weekly change	+56.9% (Feb 17, 2016)
Weeks tracked	171
Tracking since	Nov 28, 2013

Price History

0.0%

+0.3%

+3.3%

+54.4%

All

+142.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the lamotrigine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of LAMICTAL XR 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LAMICTAL XR 250 MG TABLET, manufactured by GlaxoSmithKline LLC, is $44.3107 per EA (NDC 00173078100), effective Jun 24, 2026.

How has the price of LAMICTAL XR 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for LAMICTAL XR 250 MG TABLET has risen 142.3%. It has been tracked across 171 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LAMICTAL XR 250 MG TABLET?

Since Nov 28, 2013, the NADAC for LAMICTAL XR 250 MG TABLET has ranged from a low of $18.2864 (Nov 28, 2013) to a high of $44.3107 (Jun 24, 2026), with a median of $41.8617 per EA.

Are there cheaper alternatives to LAMICTAL XR 250 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LAMICTAL XR 250 MG TABLET, so no direct lower-cost alternative is listed.